Group 4 Created with Sketch.
Vurbl Verified Station

Medicine Matters oncology

Play All
16 Subscribers
Share Path Report
Interviews with clinical experts, discussing key issues in oncology. Continue Reading >>
Interviews with clinical experts, discussing key issues in oncology. << Show Less
Featured Audio
COVID-19 vaccination in patients with cancer (with Narjust Duma) We speak to medical oncologist Narjust Duma, from the University of Wisconsin in the USA, about COVID-19 vaccination in people with cancer, discussing issues such as vaccine timing, side-effects, and key unanswered research questions.
Newest Audio
COVID-19 vaccination in patients with cancer (with Narjust Duma) We speak to medical oncologist Narjust Duma, from the University of Wisconsin in the USA, about COVID-19 vaccination in people with cancer, discussing issues such as vaccine timing, side-effects, and key unanswered research questions.
Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman) In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials. Find more on Medicine Matters oncology
The UK Coronavirus Cancer Monitoring Project: What you need to know (with Lennard Lee) Co-project leader Lennard Lee talks about the inception and development of the initiative that will provide insight into the impact of COVID-19 on people with cancer and facilitate shared learning that will benefit patient care. Find more on Medicine Matters oncology
CCC19: Introducing The COVID-19 and Cancer Consortium (with Gilberto Lopes) Gilberto Lopes (Sylvester Comprehensive Cancer Center at the University of Miami, Florida, USA), a steering committee member of CCC19, tells us about the registry collating data on cancer patients with comorbid COVID-19 to provide an evidence base for future decision-making. Find more on Medicine Matters oncology Image credit: © koto_feja/Getty Images/iStock
COVID-19 and cancer: Changing practices to meet patient needs (with Beth Sandy) Thoracic oncology nurse practitioner Beth Sandy explains how the coronavirus pandemic is affecting cancer patient care and how strategies such as telemedicine are coming into their own. Find more on Medicine Matters oncology Image credit: Coronavirus illustration © dottedyeti/stock.adobe.com
Managing patients with genitourinary cancers in the time of COVID-19 (with Cora Sternberg) Genitourinary oncologists Cora Sternberg (Weill Cornell Medicine, New York, USA) and Axel Merseburger (University Hospital Schleswig-Holstein, Lübeck, Germany) share their experience of managing cancer patients during the COVID-19 pandemic, comparing perspectives from a US and German stand point. Find more on Medicine Matters oncology
COVID-19 and cancer patient care: A lung cancer specialist’s experience (with Gilberto Lopes) Gilberto Lopes discusses the impact of the COVID-19 pandemic on the management of patients with lung cancer and outlines the measures being implemented to minimize the risk for patients. Find more on Medicine Matters oncology
Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay) Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation –  in patients with locally advanced or metastatic non-small-cell lung cancer. Find more on Medicine Matters oncology More from WCLC 2019
SUMIT: Selumetinib in metastatic uveal melanoma (with Paul Nathan) Advisory Board member and study author Paul Nathan, from the Mount Vernon Cancer Centre in Middlesex, UK, discusses the phase III SUMIT trial, which evaluated the addition of the MEK inhibitor selumetinib to dacarbazine in patients with metastatic uveal melanoma. Find more on Medicine Matters oncology This content was originally published on Medicine Matters oncology (https://oncology.medicinematters.com/) on May 4, 2018.
Load More Audio